Keyphrases
5-year Survival
5%
Adipose-derived Stromal Cells
22%
AMD3100
6%
Beige Adipocytes
21%
Biliary Tract Cancer
21%
Bone Metastasis
9%
C-X-C Chemokine Receptor Type 4 (CXCR4)
12%
Cancer Treatment
5%
Cancer-specific
5%
CD138
5%
Cell Surface
10%
Cell Targeting
21%
Chemokine Ligand 12 (CXCL12)
18%
Chemoresistance
21%
Cisplatin
6%
Coextinction
5%
CXCR7
21%
Decision Support
12%
Discovery Platforms
5%
Disease Development
5%
EAF1
21%
Early Lesions
5%
ECE1
5%
Epithelial-mesenchymal Transition
21%
Fat Tissue
6%
Fibroblast Growth Factor Receptor 1 (FGFR1)
21%
Functional Cells
5%
Functional Impact
21%
Functional Target
5%
Genetic Control
5%
Genetic Extinction
5%
Genetic Modification
7%
Glucose Metabolism
21%
Glycolysis
7%
Hereafter
5%
In Cancer
6%
Investigational Agents
6%
Knockdown
6%
KRAS Signaling
10%
Macropinocytosis
21%
Malignancy
6%
Malignant Transformation
5%
Malignant Tumor
5%
MAPK Signaling
7%
MEK Inhibitor (MEKi)
21%
Metabolic Pathway
5%
Metastatic Progression
21%
Model Precision
21%
Mouse Model
13%
Obese Mice
27%
Obesity
21%
Oncogene-driven
5%
Oncogenic Process
5%
OXCT1
10%
Pancreatic Cancer
42%
Pancreatic Duct Cells
10%
Pancreatic Ductal Adenocarcinoma
42%
Partial Response
6%
Patient-derived Xenograft
21%
PDGFR Signaling
21%
Platelet-derived Growth Factor Receptor (PDGFR)
21%
Precision Oncology
34%
Progenitor Cell Differentiation
21%
Progressive Disease
6%
Prostate Cancer
64%
Prostate Cancer Cells
9%
Prostate Cancer Progression
6%
Protein Expression
7%
Recurrent Disease
5%
RNA Sequencing (RNA-seq)
7%
Salvage Pathway
5%
Signaling Axis
21%
Specific Vulnerability
5%
Surface Proteins
5%
Surfaceome
21%
Syndecan-1
21%
Target Discovery
5%
Tumor
12%
Tumor Aggressiveness
6%
Tumor Growth
5%
Tumor Maintenance
10%
Tumor Volume
9%
Uncertain Significance
21%
Variants of Uncertain Significance
21%
White Adipocytes
21%
Xenograft
5%
Biochemistry, Genetics and Molecular Biology
2-Deoxy-D-Glucose
5%
Adipocyte
24%
Androgen Receptor
32%
Cancer Cell
51%
Cancer Model
10%
Cell Cycle
10%
Cell Survival
7%
Cell Viability
21%
Cellular Differentiation
21%
Cisplatin
8%
COL4A2
5%
Comparative Genomic Hybridization
10%
CXCL2
7%
CXCR4
15%
CXCR7
21%
DNA Synthesis
10%
Drive
21%
Drug Resistance
28%
Endoplasmic Reticulum Stress
5%
Enzyme
8%
extracellular signal regulated kinase
5%
Fibroblast
14%
Fibroblast Growth Factor Receptor 1
21%
Functional Genomics
21%
Gemcitabine
14%
Genetic Screen
5%
Genetics
5%
Genomics
32%
Glucose Metabolism
21%
High Risk Population
5%
Immunity
5%
Ketone Body
21%
Kinase
7%
KRAS
58%
Long Non-Coding RNA
21%
Low Drug Dose
5%
Low Risk Population
5%
m6A Methylation
5%
MAPK Signaling
24%
MEK Inhibitor
5%
Mesenchymal-Epithelial Transition
21%
Metabolic Pathway
11%
Mouse Model
31%
Mouse Mutant
24%
Myc
21%
N6-Methyladenosine
21%
Oncogene
21%
Overall Survival
5%
P53
21%
Paralogy
10%
Patient Coding
7%
Phosphotransferase
7%
Principal Component Analysis
5%
Progenitor Cell
21%
Programmed Cell Death
10%
Protein Expression
24%
RNA
5%
Secretion (Process)
7%
SPOP
21%
Statin
14%
Stromal Cell
27%
Synapsin I
21%
Transcription
5%
Transcription Factor E2F
10%
Transcriptomics
9%
Tumor Progression
13%
Tumor Suppressor Protein
21%
WNT5A
8%
Medicine and Dentistry
Adipose Tissue
21%
Androgen
7%
B Cell
7%
Biliary Duct Cancer
8%
Biliary Tract Cancer
21%
Bone Metastasis
14%
Cancer
8%
Cancer Cell
20%
Cancer Growth
12%
Cancer Model
6%
Carcinogenesis
7%
CD3 Antigen
7%
Cell Line
6%
Cell Surface
8%
Cell Viability Assay
7%
Cellular Infiltration
7%
Cisplatin
8%
Cooperation
7%
Diseases
8%
Downregulation
7%
Drive
21%
Drug Resistance
23%
Fibrinogen
7%
Fibroblast Growth Factor Receptor 1
21%
Functional Genomics
7%
Gleason Score
7%
Glucose Metabolism
21%
Homeostasis
7%
In Vitro
5%
Macropinocytosis
21%
Malignant Neoplasm
13%
MAPK Signaling
8%
Mediator
25%
Mesenchymal-Epithelial Transition
21%
Neoplasm
58%
Oncology
21%
Pancreas Adenocarcinoma
64%
Pancreas Cancer
64%
Plerixafor
8%
Precision Oncology
21%
Progressive Disease
8%
Prostate Cancer
100%
Prostate Tumor
9%
Prostatic Intraepithelial Neoplasia
21%
Protein Expression
11%
Prothrombin
7%
RNA Sequence
10%
Stromal Cell
25%
Syndecan 1
21%
T Cell
7%
Therapy Development
21%
Transcription Elongation Factor
7%
Tumor Progression
8%
Tumor Suppressor Protein
14%
Xenograft
47%